Free shipping on orders $50+

ViveSpan
Feverfew — front

HSA/FSA eligible with Flex

Pay with pre-tax dollars — a quick eligibility check happens at checkout.

Foundational

Feverfew

NOW Foods · 175mg standardized extract/day (1 capsule; 325mg total capsule weight including powder); label permits up to 2 capsules/day (350mg standardized extract/day, 650mg total capsule weight)

MSRP $17.99
Temporarily out of stock. It stays in your plan and ships as soon as it's back — nothing is charged until then.
1 capsule · daily, with food

Log in or create an account, then take the 5-minute health assessment to see your price.

Log inNew here? Create an account

✛ Why it's used

Feverfew is an herb that has been traditionally used by European herbalists for centuries. More modern research indicates that its main bioactive compound is parthenolide. NOW® Feverfew is standardized to 0.5% - 0.7% parthenolide per capsule.

Standardized Extract.

0.5% - 0.7% Parthenolide.

Suggested use

Take 1 capsule 1 to 2 times daily, preferably with food.

Supplement facts

Serving size 1 CapsuleServings per container 100
Amount per serving
Feverfew Extract (Tanacetum parthenium) (Aerial Parts) (min. 0.5% - 0.7% Parthenolide)175 mg
Feverfew Powder (Tanacetum parthenium) (Aerial Parts)150 mg

Other ingredients: Hypromellose (cellulose capsule), Microcrystalline Cellulose, Stearic Acid (vegetable source) and Silicon Dioxide. Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish, shellfish or tree nut ingredients. Produced in a GMP facility that processes other ingredients containing these allergens. This product is Dairy Free, Kosher, Non-GMO, Vegan/ Vegetarian.

Dietary considerations · Gluten free · Dairy free · Soy free · Egg free · Wheat free · Yeast free · Crustacean Shellfish Free

Listed under Nutritional Supplements > Inflammation Support > Inflammation Support Formulas

⚠ Key cautions

Cautions: CONTRAINDICATED in pregnancy — feverfew has traditional uterine-stimulant/emmenagogue use; may trigger mild transient oral or GI discomfort; abrupt discontinuation after prolonged use has been associated with rebound headache ('post-feverfew syndrome') — taper if discontinuing after long-term use. Prescription interactions: mild antiplatelet effect — caution with anticoagulants/antiplatelets (bleeding risk); NSAIDs may theoretically reduce feverfew's antimigraine efficacy; contraindicated in Asteraceae/Compositae family allergy (ragweed, daisies, chrysanthemums, marigolds). Priority: High — clear pregnancy contraindication plus established bleeding-risk interaction.